These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 1833782)
21. Similar pharmacological properties of 8-OH-DPAT and alnespirone (S 20499) at dopamine receptors: comparison with buspirone. Protais P; Lesourd M; Comoy E Eur J Pharmacol; 1998 Jul; 352(2-3):179-87. PubMed ID: 9716353 [TBL] [Abstract][Full Text] [Related]
22. Characterization of MDL 73005EF as a 5-HT1A selective ligand and its effects in animal models of anxiety: comparison with buspirone, 8-OH-DPAT and diazepam. Moser PC; Tricklebank MD; Middlemiss DN; Mir AK; Hibert MF; Fozard JR Br J Pharmacol; 1990 Feb; 99(2):343-9. PubMed ID: 1970269 [TBL] [Abstract][Full Text] [Related]
23. Dopamine receptor blockade in nucleus accumbens or caudate nucleus differentially affects feeding induced by 8-OH-DPAT injected into dorsal or median raphe. Fletcher PJ Brain Res; 1991 Jun; 552(2):181-9. PubMed ID: 1833034 [TBL] [Abstract][Full Text] [Related]
24. Pharmacological characterization of 8-OH-DPAT-induced inhibition of rat hippocampal 5-HT release in vivo as measured by microdialysis. Sharp T; Bramwell SR; Hjorth S; Grahame-Smith DG Br J Pharmacol; 1989 Nov; 98(3):989-97. PubMed ID: 2574066 [TBL] [Abstract][Full Text] [Related]
25. The effects of 8-hydroxy-2-(di-n-propylamino)tetralin on the cholinergic contraction in guinea pig and human airways in vitro. Dupont LJ; Pype JL; Demedts MG; De Leyn P; Deneffe G; Verleden GM Am J Respir Crit Care Med; 1998 Nov; 158(5 Pt 1):1479-86. PubMed ID: 9817696 [TBL] [Abstract][Full Text] [Related]
26. Activation of the 5-HT1A receptor subtype increases rat plasma ACTH concentration. Gilbert F; Brazell C; Tricklebank MD; Stahl SM Eur J Pharmacol; 1988 Mar; 147(3):431-9. PubMed ID: 2897920 [TBL] [Abstract][Full Text] [Related]
27. Characterization of 8-OH-DPAT-induced hypothermia in mice as a 5-HT1A autoreceptor response and its evaluation as a model to selectively identify antidepressants. Martin KF; Phillips I; Hearson M; Prow MR; Heal DJ Br J Pharmacol; 1992 Sep; 107(1):15-21. PubMed ID: 1422568 [TBL] [Abstract][Full Text] [Related]
28. Mediation of the antidepressant-like effect of 8-OH-DPAT in mice by postsynaptic 5-HT1A receptors. Luscombe GP; Martin KF; Hutchins LJ; Gosden J; Heal DJ Br J Pharmacol; 1993 Mar; 108(3):669-77. PubMed ID: 8467355 [TBL] [Abstract][Full Text] [Related]
29. Functional topography of brain serotonergic pathways in the rat. Hillegaart V Acta Physiol Scand Suppl; 1991; 598():1-54. PubMed ID: 1832809 [TBL] [Abstract][Full Text] [Related]
30. Chronic, combined treatment with desipramine and mianserin: enhanced 5-HT1A receptor function and altered 5-HT1A/5-HT2 receptor interaction in rats. Lund A; Mjellem N Pharmacol Biochem Behav; 1993 Aug; 45(4):777-83. PubMed ID: 8415816 [TBL] [Abstract][Full Text] [Related]
31. The role of the central serotonergic system in pilocarpine-induced seizures: receptor mechanisms. Janusz W; Kleinrok Z Neurosci Res; 1989 Nov; 7(2):144-53. PubMed ID: 2533336 [TBL] [Abstract][Full Text] [Related]
32. Dose-dependent effects of buspirone on behavior and cerebral glucose metabolism in rats. Freo U; Pietrini P; Pizzolato G; Furey-Kurkjian M; Merico A; Ruggero S; Dam M; Battistin L Brain Res; 1995 Apr; 677(2):213-20. PubMed ID: 7552245 [TBL] [Abstract][Full Text] [Related]
33. Drug-induced defaecation in rats: role of central 5-HT1A receptors. Croci T; Landi M; Bianchetti A; Manara L Br J Pharmacol; 1995 May; 115(1):203-9. PubMed ID: 7647978 [TBL] [Abstract][Full Text] [Related]
34. Activity of serotonin (5-HT) receptor agonists, partial agonists and antagonists at cloned human 5-HT1A receptors that are negatively coupled to adenylate cyclase in permanently transfected HeLa cells. Pauwels PJ; Van Gompel P; Leysen JE Biochem Pharmacol; 1993 Jan; 45(2):375-83. PubMed ID: 8382063 [TBL] [Abstract][Full Text] [Related]
35. Ketanserin-sensitive depressant actions of 5-HT receptor agonists in the neonatal rat spinal cord. Manuel NA; Wallis DI; Crick H Br J Pharmacol; 1995 Nov; 116(6):2647-54. PubMed ID: 8590984 [TBL] [Abstract][Full Text] [Related]
36. Single-unit responses of serotonergic dorsal raphe neurons to 5-HT1A agonist and antagonist drug administration in behaving cats. Fornal CA; Litto WJ; Metzler CW; Marrosu F; Tada K; Jacobs BL J Pharmacol Exp Ther; 1994 Sep; 270(3):1345-58. PubMed ID: 7932189 [TBL] [Abstract][Full Text] [Related]
37. The behavioural effects of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) in mice. Yamada J; Sugimoto Y; Horisaka K Eur J Pharmacol; 1988 Sep; 154(3):299-304. PubMed ID: 2976671 [TBL] [Abstract][Full Text] [Related]
38. The effects of rubidium, caesium and quinine on 5-HT-mediated behaviour in rat and mouse--3. Quinine. Wang H; Grahame-Smith DG Neuropharmacology; 1992 May; 31(5):425-31. PubMed ID: 1388254 [TBL] [Abstract][Full Text] [Related]
39. Effects of selective serotonin and dopamine agonists on plasma levels of glucose, insulin and glucagon in the rat. Uvnäs-Moberg K; Ahlenius S; Alster P; Hillegaart V Neuroendocrinology; 1996 Mar; 63(3):269-74. PubMed ID: 8677015 [TBL] [Abstract][Full Text] [Related]
40. Behavioural evidence for a functional interaction between central 5-HT2 and 5-HT1A receptors. Backus LI; Sharp T; Grahame-Smith DG Br J Pharmacol; 1990 Aug; 100(4):793-9. PubMed ID: 2145051 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]